Last quarter (Q2 2023), MedAvail Holdings's total revenue was $278.00K, a decrease of -97.51% from the same quarter last year. In Q2, MedAvail Holdings's net income was $-5.79M. See MedAvail Holdings’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 22	Dec 21	Dec 20	Dec 19
Total Revenue	$ 23.41M	$ 43.11M	$ 22.13M	$ 13.97M	$ 3.77M
Cost of Revenue	$ 80.12M	$ 40.52M	$ 21.81M	$ 8.80M	$ 2.82M
Gross Profit	$ 1.83M	$ 2.58M	$ 317.00K	$ 5.16M	$ 948.00K
Operating Expense	$ 110.08M	$ 49.01M	$ 43.83M	$ 25.97M	$ 21.66M
Operating Income	$ -31.70M	$ -46.42M	$ -43.51M	$ -20.81M	$ -20.71M
Net Non Operating Interest Income Expense	$ -957.00K	$ -1.17M	$ -589.00K	$ -1.20M	$ -689.00K
Other Income Expense	$ -1.89M	$ -2.00K	$ -285.00K	$ -4.80M	$ -137.00K
Pretax Income	$ -40.93M	$ -47.59M	$ -43.81M	$ -26.81M	$ -21.53M
Tax Provision	-	$ 24.00K	$ 2.00K	$ 0.00	$ 0.00
Earnings From Equity Interest Net Of Tax	-	-	-	-	-
Net Income Common Stockholders	$ -41.23M	$ -47.62M	$ -43.81M	$ -26.81M	$ -21.53M
Basic EPS	$ -3.44	$ -0.72	$ -1.34	$ -4.69	$ -0.68
Diluted EPS	$ -3.44	$ -0.72	$ -1.34	$ -4.69	$ -0.68
Basic Average Shares	$ 147.85M	$ 65.78M	$ 32.66M	$ 5.72M	$ 31.67M
Diluted Average Shares	$ 147.85M	$ 65.78M	$ 32.66M	$ 5.72M	$ 31.67M
Dividend Per Share	-	-	-	-	-
Total Operating Income As Reported	-	-	-	-	-
Reported Normalized Basic E P S	-	-	-	-	-
Reported Normalized Diluted E P S	-	-	-	-	-
Rent Expense Supplemental	$ 1.31M	-	-	$ 1.52M	$ 1.34M
Total Expenses	$ 190.20M	$ 89.53M	$ 65.64M	$ 34.78M	$ 24.48M
Net Income From Continuing And Discontinued Operation	$ -46.00M	$ -47.62M	$ -43.81M	$ -26.81M	$ -21.53M
Normalized Income	$ -16.15M	-	-	$ -22.30M	$ -21.40M
Interest Expense	$ 315.00K	-	-	$ 1.24M	$ 734.00K
EBIT	$ -39.97M	$ -46.42M	$ -43.22M	$ -25.57M	$ -20.80M
EBITDA	$ -35.28M	$ -41.78M	$ -40.46M	$ -23.76M	$ -19.16M

Currency in USD

MedAvail Holdings Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing